Stay updated with breaking news from Beth Kirkpatrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Friday, Oct. 1, 2021 Booster shots now available for more Vermonters MONTPELIER —The Agency of Human Services and the Department of Health announced that Pfizer-BioNTech COVID-19 vaccine booster doses are now available to people in Vermont who are 65 and ...
Sorely Needed Dengue Vaccine Gets a Boost from Immune Profiling Source: Pixabay May 26, 2021 A new study in the journal Nature Communications compares changes in gene expression in immune cells in humans before, during, and after infection with a partially weakened Dengue virus (rDEN2Δ30, ClinicalTrials.gov NCT02021968). Live, weakened or “attenuated” viruses are the basis for the most effective and durable vaccines against many viral diseases. The study finds that while the expression of some inflammatory genes, such as genes for type I interferon and viral restriction pathways, incre...
E-Mail Despite a daunting more than 130 million cases of SARS-CoV-2 infections to date worldwide, another global pathogen - the Aedes mosquito-borne dengue virus - saw a record number of over 400 million cases in 2019. But vaccine development has been challenging due to the need to protect equally against all four dengue strains. The discovery of new possible biomarkers to predict clinical and immune responses to dengue virus infection, published today in Nature Communication, could be critical to informing future vaccines. As with SARS-CoV-2 infection, the effects of dengue virus infectio...
UVM Medical Center pushing forward with AstraZeneca COVID-19 vaccine trial Several countries suspend use of the AstraZeneca vaccine. Share Updated: 7:09 PM EDT Mar 15, 2021 Several countries suspend use of the AstraZeneca vaccine. Share Updated: 7:09 PM EDT Mar 15, 2021 Hide Transcript Show Transcript NBC5 NEWS AT 6 STARTS NOW FOUR OF THE SIX... MOST POPULATED EUROPEAN COUNTRIES. ááSUSPENDING USE OF THE ASTRA ZENCA VACCINE. THANKS FOR JOINING US AT 6. I'M BRIAN COLLERAN. AND I'M ALICE KANG. THE DECISION COMES AFTER CONCERNS OVER POSSIBLE SIDE- EFFECTS. B...
Joshua Schupp-Star getting vaccinated Joshua Schupp-Star can give you many reasons why he volunteered to join the clinical trial of an experimental COVID-19 vaccine at the University of Vermont's Vaccine Testing Center. All can be summarized in one word: hope. "After receiving my first dose, I got a taste of the freedom that existed before the pandemic," said Schupp-Star, who is among the 284 volunteers in Vermont to receive an as-yet-unapproved vaccine made by British-Swedish drug manufacturer AstraZeneca. "It's such a liberating feeling to walk...